TY - JOUR AU - McLennan, G. AU - Roder, D. M. PY - 1989 DA - 1989// TI - Lung cancer in Australia JO - Med J Aust VL - 150 ID - McLennan1989 ER - TY - JOUR AU - Burton, R. C. PY - 2002 DA - 2002// TI - Cancer control in Australia: into the 21 (st) Century JO - Jpn J Clin Oncol VL - 32 UR - https://doi.org/10.1093/jjco/hye121 DO - 10.1093/jjco/hye121 ID - Burton2002 ER - TY - JOUR AU - Hansen, H. H. PY - 2002 DA - 2002// TI - Treatment of advanced non-small cell lung cancer JO - BMJ VL - 325 UR - https://doi.org/10.1136/bmj.325.7362.452 DO - 10.1136/bmj.325.7362.452 ID - Hansen2002 ER - TY - JOUR AU - Cridelli, C. PY - 2004 DA - 2004// TI - Targeted therapies in the treatment of non small cell lung cancer: JO - Curr Opin Oncol VL - 26 UR - https://doi.org/10.1097/00001622-200403000-00007 DO - 10.1097/00001622-200403000-00007 ID - Cridelli2004 ER - TY - JOUR AU - Evans, T. L. AU - Lynch, T. J. PY - 2001 DA - 2001// TI - Lung Cancer JO - Oncologist VL - 6 UR - https://doi.org/10.1634/theoncologist.6-5-407 DO - 10.1634/theoncologist.6-5-407 ID - Evans2001 ER - TY - JOUR AU - Weichselbaum, R. R. AU - Hallahan, D. E. AU - Beckett, M. A. PY - 1994 DA - 1994// TI - Gene therapy targeted by radiation preferentially radiosensitizes tumor cells JO - Cancer Res VL - 54 ID - Weichselbaum1994 ER - TY - JOUR AU - Gallardo, D. AU - Drazan, K. E. AU - Mcbride, W. H. PY - 1996 DA - 1996// TI - Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity JO - Cancer Res VL - 56 ID - Gallardo1996 ER - TY - JOUR AU - Rogulski, K. R. AU - Kim, J. H. AU - Kim, S. H. PY - 1997 DA - 1997// TI - Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity JO - Hum Gene Ther VL - 8 UR - https://doi.org/10.1089/hum.1997.8.1-73 DO - 10.1089/hum.1997.8.1-73 ID - Rogulski1997 ER - TY - JOUR AU - Wakeling, A. E. PY - 2002 DA - 2002// TI - Epidermal growth factor receptor tyrosine kinase inhibitors JO - Curr Opin Pharmacol VL - 2 UR - https://doi.org/10.1016/S1471-4892(02)00183-2 DO - 10.1016/S1471-4892(02)00183-2 ID - Wakeling2002 ER - TY - JOUR AU - Wakeling, A. E. AU - Guy, S. P. AU - Woodburn, J. R. PY - 2002 DA - 2002// TI - ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy JO - Cancer Res VL - 62 ID - Wakeling2002 ER - TY - JOUR AU - Shin, D. M. AU - Donato, N. J. AU - Perez-Soler, R. PY - 2001 DA - 2001// TI - Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer JO - Clin Cancer Res VL - 7 ID - Shin2001 ER - TY - JOUR AU - Ciardiello, F. AU - Caputo, R. AU - Blanco, R. PY - 2000 DA - 2000// TI - Inhibition of growth factor production and angiogenesis in human cancer cells by ZD-1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor JO - Clin Cancer Res VL - 7 ID - Ciardiello2000 ER - TY - JOUR AU - Shawver, L. K. AU - Slamon, D. AU - Ulrich, A. PY - 2002 DA - 2002// TI - Smart drugs: tyrosine kinase inhibitors in cancer therapy JO - Cancer Cell VL - 1 UR - https://doi.org/10.1016/S1535-6108(02)00039-9 DO - 10.1016/S1535-6108(02)00039-9 ID - Shawver2002 ER - TY - JOUR AU - Baselga, J. PY - 2001 DA - 2001// TI - The EGFR as a target for anticancer therapy – focus on cetuximab JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00233-7 DO - 10.1016/S0959-8049(01)00233-7 ID - Baselga2001 ER - TY - JOUR AU - Tamm, I. AU - Dorken, B. AU - Hartmann, G. PY - 2001 DA - 2001// TI - Antisense therapy in oncology, new hope for an old idea? JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)05629-X DO - 10.1016/S0140-6736(01)05629-X ID - Tamm2001 ER - TY - JOUR AU - Elbashir, S. M. AU - Lendechel, W. AU - Tuschl, T. PY - 2001 DA - 2001// TI - RNA interference is mediated by 21- and 22-nucleotide RNAs JO - Genes Dev VL - 15 UR - https://doi.org/10.1101/gad.862301 DO - 10.1101/gad.862301 ID - Elbashir2001 ER - TY - JOUR AU - Hammond, S. M. AU - Caudy, A. A. AU - Hannon, G. J. PY - 2001 DA - 2001// TI - Post transcriptional gene silencing by double stranded RNA JO - Nat Rev Genet VL - 2 UR - https://doi.org/10.1038/35052556 DO - 10.1038/35052556 ID - Hammond2001 ER - TY - JOUR AU - Elbashir, S. M. AU - Harborth, J. AU - Lendechel, W. PY - 2001 DA - 2001// TI - Duplexes of 21-nucleotides RNAs mediate RNA interference in cultured mammalian cells JO - Nature VL - 411 UR - https://doi.org/10.1038/35078107 DO - 10.1038/35078107 ID - Elbashir2001 ER - TY - JOUR AU - Christen, R. D. AU - Hom, D. K. AU - Porter, D. C. PY - 1990 DA - 1990// TI - Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin JO - J Clin Invest VL - 86 UR - https://doi.org/10.1172/JCI114885 DO - 10.1172/JCI114885 ID - Christen1990 ER - TY - JOUR AU - Kroning, R. AU - Jones, J. A. AU - Hom, D. K. PY - 1995 DA - 1995// TI - Enhancement of drug sensitivity of human malignancies by epidermal growth factor JO - Br J Cancer VL - 72 UR - https://doi.org/10.1038/bjc.1995.382 DO - 10.1038/bjc.1995.382 ID - Kroning1995 ER - TY - JOUR AU - Zhang, M. AU - Zhang, X. AU - Bai, C. X. AU - Chen, J. AU - Wei, M. Q. PY - 2004 DA - 2004// TI - Inhibition of epidermal growth factor receptor (EGFR) by RNA interference in A549 cells JO - Acta Pharmacol Sin VL - 25 ID - Zhang2004 ER - TY - JOUR AU - Lal, A. AU - Glazer, C. A. AU - Martinson, H. M. PY - 2002 DA - 2002// TI - Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion JO - Cancer Res VL - 62 ID - Lal2002 ER - TY - JOUR AU - Liu, C. S. AU - Kong, B. H. AU - Xia, H. Q. PY - 2001 DA - 2001// TI - VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death JO - J Gene Med VL - 3 UR - https://doi.org/10.1002/jgm.164 DO - 10.1002/jgm.164 ID - Liu2001 ER - TY - JOUR AU - Metharom, P. AU - Tayra, S. AU - Xia, H. Q. AU - MacMillian, J. AU - Shepherd, R. AU - Wilcox, G. AU - Wei, M. Q. PY - 2002 DA - 2002// TI - New bovine lentiviral vectors based on the Jembrana disease virus JO - J Gene Medicine VL - 2 UR - https://doi.org/3.0.CO;2-Q DO - 3.0.CO;2-Q ID - Metharom2002 ER - TY - JOUR AU - Zhang, B. AU - Xia, H. Q. AU - Cleghorn, G. AU - Gobe, G. AU - West, M. AU - Wei, M. Q. PY - 2001 DA - 2001// TI - A highly efficient and consistent method for harvesting large volumes of high titre lentiviral vectors JO - Gene Therapy VL - 8 UR - https://doi.org/10.1038/sj.gt.3301587 DO - 10.1038/sj.gt.3301587 ID - Zhang2001 ER - TY - JOUR AU - Nagy, P. AU - Arndt-Jovin, D. J. AU - Jovin, T. M. PY - 2003 DA - 2003// TI - Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells JO - Exp Cell Res VL - 285 UR - https://doi.org/10.1016/S0014-4827(02)00050-2 DO - 10.1016/S0014-4827(02)00050-2 ID - Nagy2003 ER - TY - JOUR AU - Nieth, C. AU - Priebsch, A. AU - Stege, A. PY - 2003 DA - 2003// TI - Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference(RNAi) JO - FEBS Lett VL - 545 UR - https://doi.org/10.1016/S0014-5793(03)00523-4 DO - 10.1016/S0014-5793(03)00523-4 ID - Nieth2003 ER - TY - JOUR AU - Tsai, C. M. AU - Chang, K. T. AU - Li, L. AU - Perng, R. P. AU - Yang, L. Y. PY - 2000 DA - 2000// TI - Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression and epidermal growth factor receptor level in non-small cell lung cancer JO - Jpn J Cancer Res VL - 91 UR - https://doi.org/10.1111/j.1349-7006.2000.tb00934.x DO - 10.1111/j.1349-7006.2000.tb00934.x ID - Tsai2000 ER - TY - JOUR AU - Somasundaram, K. PY - 2003 DA - 2003// TI - Stable RNA interference (RNAi) in mammalian cells JO - Cancer Biol Ther VL - 2 UR - https://doi.org/10.4161/cbt.2.2.358 DO - 10.4161/cbt.2.2.358 ID - Somasundaram2003 ER - TY - JOUR AU - Magne, N. AU - Fischel, J. L. AU - Dubreuil, A. PY - 2002 DA - 2002// TI - Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer JO - Br J Cancer VL - 86 UR - https://doi.org/10.1038/sj.bjc.6600103 DO - 10.1038/sj.bjc.6600103 ID - Magne2002 ER - TY - JOUR AU - Hirata, A. AU - Ogawa, S. AU - Kometani, T. PY - 2002 DA - 2002// TI - ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase 2 JO - Cancer Res VL - 62 ID - Hirata2002 ER - TY - JOUR AU - Nakagawa, K. PY - 2001 DA - 2001// TI - Tyrosine kinase inhibitors-solid cancers JO - Gan To Kagaku Ryoho VL - 28 ID - Nakagawa2001 ER - TY - JOUR AU - Huang, S. M. AU - Li, J. AU - Armstrong, E. A. PY - 2002 DA - 2002// TI - Modulation of radiation response and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa) JO - Cancer Res VL - 62 ID - Huang2002 ER - TY - JOUR AU - Williams, K. J. AU - Telfer, B. A. AU - Stratford, I. J. PY - 2002 DA - 2002// TI - ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenegraft model JO - Br J Cancer VL - 86 UR - https://doi.org/10.1038/sj.bjc.6600182 DO - 10.1038/sj.bjc.6600182 ID - Williams2002 ER -